Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

AT&T's 6.4% Yield Looks Great After Earnings... But There's Bad News, Too


U.S. wireless carrier AT (NYSE: T) recently closed out its fiscal 2023 year with earnings. The company, popular with income-focused investors, got great news regarding its financials and how they may affect its dividend moving forward.

However, it wasn't all sunshine. The company is coming up short in one crucial area that could limit the stock's total returns upside. AT remains a somewhat controversial stock that may or may not fit your portfolio.

AT is one of a handful of companies that dominate the wireless communications market in the United States. The company has been around for ages because communications are a consistent part of our daily lives. While the business has primarily moved from landlines to cellphones, the same companies still build and maintain the networks.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,050 €
-5,71 %
Stark abwärts geht es heute für die Allergy Therapeutics PLC Aktie. Seit gestern notiert das Papier um -5,71 % tiefer.

Like: 0
T
Teilen

Kommentare